Article

Nanobodies Targeting ABCC3 for Immunotargeted Applications in Glioblastoma

2022-07-13

Abstract excerpt

The cancer “omics” reveal many clinically relevant alterations that are transforming the molecular characterization of glioblastomas. However, many of these findings are not yet translated into clinical practice due, in part, to the lack of non-invasive biomarkers and the limitations imposed by the blood-brain barrier. Nanobodies, camelid single-domain antibody fragments, emerge as a promising tool for immunotarge...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ed2e80de-756e-5a25-9ff9-ec027fb64a74
DOI: 10.21203/rs.3.rs-1730534/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Nanobodies Targeting ABCC3 for Immunotargeted Applications in GlioblastomaDOI 10.21203/rs.3.rs-1730534/v1Read

Nanobodies effectively modulate the enzymatic activity of CD38 and allow specific imaging of CD38+ tumors in mouse models in vivoSemantic proximity Read

Universal Dual-Target CAR-γδT Cells Targeting B7-H3 and IL13Rα2 for Glioblastoma TherapySemantic proximity Read

CD276 (B7-H3) as a Companion Diagnostic Biomarker for Glioblastoma: Multi-Platform Validation and Therapeutic ImplicationsSemantic proximity Read

A novel and effective approach to generate germline-like monoclonal antibodies by integration of phage and mammalian cell display platformsSemantic proximity Read

Nanobodies against surface biomarkers enable the analysis of tumor genetic heterogeneity in uveal melanoma patient‐derived xenograftsSemantic proximity Read

Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell MalignanciesSemantic proximity Read

The Application of Nanobody in CAR-T TherapySemantic proximity Read

Highly reliable GIGA-sized synthetic human therapeutic antibody library constructionSemantic proximity Read

Antibody-drug conjugates in glioblastoma therapy: the right drugs to the right cells.Semantic proximity Read

Nanobodies targeting EGFR provide insight into conformations stabilized by glioblastoma mutations.Semantic proximity Read

Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignanciesSemantic proximity Read

Expression of ABCB1, ABCC1 and 3 and ABCG2 in glioblastoma and their relevance in relation to clinical survival surrogatesSemantic proximity Read